Year: 2008

A Randomised Double-Blind, Placebo-and-Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Extended –Release (ER) in Subjects with Moderate to Severe Pain Due to Osteoarthritis of the Knee.

Sponsor:
Janssen Cilag
CRO:
Kendle
Study ID:
R331333PAI3008
Phase:
N/A